Search
Simvastatin
go.drugbank.com/drugs/DB00641ApprovedInvestigational"bad cholesterol"), and very low-density lipoprotein (VLDL). … [A181409,A181535,A181538,A1793] Potency is thought to correlate to tissue permeability as the more lipophilic statins such as simvastatin are thought to enter endothelial cells by passive diffusion, as
Mixtures: VALCORE TABLET 10MG/10MG, VYTORIN ® 10/10MGProducts: STATIN 10MG, SIMVALIP 10MGMebendazole
go.drugbank.com/drugs/DB00643ApprovedInvestigationalVet approvedA benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]
Products: PRIMEDAZOL TABLET 100MG, THELMOX TABLET 100MGRitonavir
go.drugbank.com/drugs/DB00503ApprovedInvestigationalAlthough it was initially developed as an independent antiviral agent, it has been shown to possess advantageous properties in combination regimens with low-dose ritonavir and other protease inhibitors … It is now more commonly used as a booster of other protease inhibitors and is available in both liquid formulations and as capsules.
Mixtures: Kaletra Tablet 100mg/25mg, Kaletra 100mg/25mg Film-Coated TabletProducts: Norvir Tablet 100mgSotalol
go.drugbank.com/drugs/DB00489ApprovedInvestigational[A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992. … [L6334] A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal sinus rhythm
Products: DAROB 160MG, Sotacor Tab 160mgPropafenone
go.drugbank.com/drugs/DB01182ApprovedInvestigationalIt also has weak beta-blocking activity. The drug is generally well tolerated.
Products: RYTMONORM 150MG, PROPAFENON HEXAL 150MGBicalutamide
go.drugbank.com/drugs/DB01128ApprovedInvestigationalBicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers. Bicalutamide binds to the androgen recep...
Products: CASODEX 150MG, BICAMED 150MGBortezomib
go.drugbank.com/drugs/DB00188ApprovedInvestigational[A204083] Bortezomib was first synthesized in 1995.[A204083] In May 2003, bortezomib became the first anticancer proteasome inhibitor that was approved by the FDA under the trade name VELCADE.
Products: MYBORTE 1.0mg (Bortezomib Powder for Solution for Injection 1.0mg/vial), PORIX® 3.5 POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLEBedaquiline
go.drugbank.com/drugs/DB08903ApprovedInvestigational[A261856,A261861] It is the first drug that was approved in the last 40 years by the FDA for TB unresponsive to current treatments on the market. … [A261861] Bedaquiline was approved by the FDA on December 28, 2012, to treat pulmonary MDR-TB, following favorable results in multiple pre-clinical and clinical studies.
Products: SIRTURO 100MG TABLETSNeomycin
go.drugbank.com/drugs/DB00994ApprovedInvestigationalVet approved[A191529] Neomycin sulfate as monotherapy is available in an oral solution for adjunct use in the treatment of hepatic coma. … [A191529] Neomycin B, also known as [framycetin], is the most active component of the complex and neomycin C is the isomer of neomycin B, making these two stereoisomers the active components of neomycin
Mixtures: Neo-poly-bac, Neo-poly-bac HydroProducts: N-bac cream, TP-NEOCIN 500 WSP NEOMYCIN SULPHATE 500MG/G POWDERSolifenacin
go.drugbank.com/drugs/DB01591ApprovedInvestigational[L7511] It has a long duration of action as it is usually taken once daily.[L7511] Solifenacin was granted FDA approval on 19 November 2004.[L7511]
Products: VESIKUR 10MG, VESICARE 10MG